Previous Article | Next Article 
J Virol, January 1998, p. 789-795, Vol. 72, No. 1
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Exchange of Viral Promoter/Enhancer Elements with
Heterologous Regulatory Sequences Generates Targeted Hybrid Long
Terminal Repeat Vectors for Gene Therapy of Melanoma
R. M.
Diaz,1
T.
Eisen,2
I. R.
Hart,1 and
R. G.
Vile3,*
Richard Dimbleby Department of Cancer
Research/ICRF Laboratory, Rayne Institute, St. Thomas' Hospital,
London SE1 7EH,1
Marie Curie Research
Institute, The Chart, Oxted, Surrey RH8 0TL,2
and
ICRF Laboratory of Molecular Therapy, ICRF Oncology Unit,
Hammersmith Hospital, London W12 0NN,3 United
Kingdom
Received 13 May 1997/Accepted 24 September 1997
To generate transcriptionally targeted vectors, tissue-specific
elements of the human tyrosinase promoter were exchanged with corresponding viral elements in the Moloney murine leukemia virus long
terminal repeat (LTR). From these experiments, a vesicular stomatitis
virus type G pseudotyped, hybrid LTR vector that contained three
tyrosinase enhancer elements and gave high-level, tightly tissue-specific expression at high titers (3 × 107
CFU/ml) was constructed.
*
Corresponding author. Mailing address: ICRF Laboratory
of Molecular Therapy, ICRF Oncology Unit, Hammersmith Hospital, DuCane Rd., London, W12 0NN. Phone: 181 383 8584. Fax: 181 383 3258. E-mail:
R.Vile{at}icrf.icnet.uk.
This article has been cited by other articles:
-
Hiraoka, K., Kimura, T., Logg, C. R., Kasahara, N.
(2006). Tumor-Selective Gene Expression in a Hepatic Metastasis Model after Locoregional Delivery of a Replication-Competent Retrovirus Vector. Clin. Cancer Res.
12: 7108-7116
[Abstract]
[Full Text]
-
Metzl, C., Mischek, D., Salmons, B., Gunzburg, W. H., Renner, M., Portsmouth, D.
(2006). Tissue- and Tumor-Specific Targeting of Murine Leukemia Virus-Based Replication-Competent Retroviral Vectors. J. Virol.
80: 7070-7078
[Abstract]
[Full Text]
-
Hlavaty, J., Stracke, A., Klein, D., Salmons, B., Gunzburg, W. H., Renner, M.
(2004). Multiple Modifications Allow High-Titer Production of Retroviral Vectors Carrying Heterologous Regulatory Elements. J. Virol.
78: 1384-1392
[Abstract]
[Full Text]
-
Crittenden, M., Gough, M., Chester, J., Kottke, T., Thompson, J., Ruchatz, A., Clackson, T., Cosset, F. L., Chong, H., Diaz, R. M., Harrington, K., Alvarez Vallina, L., Vile, R.
(2003). Pharmacologically Regulated Production of Targeted Retrovirus from T Cells for Systemic Antitumor Gene Therapy. Cancer Res.
63: 3173-3180
[Abstract]
[Full Text]
-
Logg, C. R., Logg, A., Matusik, R. J., Bochner, B. H., Kasahara, N.
(2002). Tissue-Specific Transcriptional Targeting of a Replication-Competent Retroviral Vector. J. Virol.
76: 12783-12791
[Abstract]
[Full Text]
-
Barzon, L., Bonaguro, R., Castagliuolo, I., Chilosi, M., Gnatta, E., Parolin, C., Boscaro, M., Palu, G.
(2002). Transcriptionally Targeted Retroviral Vector for Combined Suicide and Immunomodulating Gene Therapy of Thyroid Cancer. J. Clin. Endocrinol. Metab.
87: 5304-5311
[Abstract]
[Full Text]
-
Bateman, A., Bullough, F., Murphy, S., Emiliusen, L., Lavillette, D., Cosset, F.-L., Cattaneo, R., Russell, S. J., Vile, R. G.
(2000). Fusogenic Membrane Glycoproteins As a Novel Class of Genes for the Local and Immune-mediated Control of Tumor Growth. Cancer Res.
60: 1492-1497
[Abstract]
[Full Text]
-
Jäger, U., Zhao, Y., Porter, C. D.
(1999). Endothelial Cell-Specific Transcriptional Targeting from a Hybrid Long Terminal Repeat Retrovirus Vector Containing Human Prepro-Endothelin-1 Promoter Sequences. J. Virol.
73: 9702-9709
[Abstract]
[Full Text]
-
Grande, A., Piovani, B., Aiuti, A., Ottolenghi, S., Mavilio, F., Ferrari, G.
(1999). Transcriptional Targeting of Retroviral Vectors to the Erythroblastic Progeny of Transduced Hematopoietic Stem Cells. Blood
93: 3276-3285
[Abstract]
[Full Text]
-
Galipeau, J., Li, H., Paquin, A., Sicilia, F., Karpati, G., Nalbantoglu, J.
(1999). Vesicular Stomatitis Virus G Pseudotyped Retrovector Mediates Effective in Vivo Suicide Gene Delivery in Experimental Brain Cancer. Cancer Res.
59: 2384-2394
[Abstract]
[Full Text]